Natco Drugs And Fine Chemicals Private Limited, a struck off private limited company, was established on 11 May 1999 in Andhra Pradesh, Telangana, India. Engaging in industrial chemicals within the chemicals sector, it holds CIN: U24110TG1999PTC031672. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹20.00 Cr and a paid-up capital of ₹0.50 M.
Its leadership includes Sadasiva Rao Nannapaneni (Director), Pathuri Srinivasa Rao (Director), Anand Babu Tummala (Director). Past directors included Sadasiva Rao Nannapaneni, Durga Devi Nannapaneni, Venkaiah Chowdary Nannapaneni. Its latest AGM occurred on 18 May 2007, with the balance sheet filed on 31 March 2007. It is based at Natco House, Road No.2Banjra Hills Hyderabad-500 033, Andhra Pradesh, Telangana, 500033.
U24110TG1999PTC031672
031672
11 May 1999
₹20.00 Cr
₹0.50 M
Roc Hyderabad
Unlisted
Struck Off
Explore comprehensive insights into Natco Drugs And Fine Chemicals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sadasiva Rao Nannapaneni | Director | 01 Mar 2006 | Current |
| Pathuri Srinivasa Rao | Director | 01 Mar 2006 | Current |
| Anand Babu Tummala | Director | 01 Mar 2006 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 30 Sep 2006 | Past |
| Pramod Abcsdd | Director | 30 Sep 2006 | Past |
| Pramod Abcsdd | Director | 30 Sep 2006 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2006 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2006 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Enhance accessibility to Natco Drugs And Fine Chemicals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Natco Drugs And Fine Chemicals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Natco Drugs And Fine Chemicals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Natco Drugs And Fine Chemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Natco Drugs And Fine Chemicals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Natco Drugs And Fine Chemicals Private Limited last Annual general meeting of members was held on 18 May 2007 as per latest MCA records. was recorded as a recent event.
Natco Drugs And Fine Chemicals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2007 with Roc Hyderabad. was recorded as a recent event.
The activity Sadasiva Rao Nannapaneni was appointed as a Director was appointed as a Director on 01 Mar 2006 & has been associated with this company since 19 years 9 months . was completed.
Progress on Pathuri Srinivasa Rao was appointed as a Director was appointed as a Director on 01 Mar 2006 & has been associated with this company since 19 years 9 months . was documented.
The activity Anand Babu Tummala was appointed as a Director was appointed as a Director on 01 Mar 2006 & has been associated with this company since 19 years 9 months . was completed.
Natco Drugs And Fine Chemicals Private Limited was registered on 11 May 1999 with Roc Hyderabad & aged 26 years 6 months as per MCA records. was recorded as a recent event.
The Delhi High Court has prohibited Natco Pharma from producing and selling the cancer drug Olaparib, marketed as 'BRACANAT' or under any other name, until further notice. The court's decision came in response to a lawsuit by Kudos Pharmaceuticals, which claimed that Natco was infringing on its patent for Olaparib. The court found Natco's challenge to the patent's validity unconvincing, leading to the injunction. Natco had sought to revoke Kudos' patent only after the lawsuit was filed, despite no previous opposition to it..
Natco Pharma has received environment clearance (EC) for its Rs 480 crore expansion project in Telangana that would generate 1,500 jobs..
The CIN of Natco Drugs And Fine Chemicals Private Limited is U24110TG1999PTC031672.
Natco Drugs And Fine Chemicals Private Limited is headquartered at Natco House, Road No.2Banjra Hills Hyderabad-500 033, Andhra Pradesh, Telangana, 500033.
Natco Drugs And Fine Chemicals Private Limited was incorporated on 11 May 1999.
The current directors of Natco Drugs And Fine Chemicals Private Limited are
The primary industry of Natco Drugs And Fine Chemicals Private Limited is Chemicals.
Natco Drugs And Fine Chemicals Private Limited is unlisted.
The authorized capital of Natco Drugs And Fine Chemicals Private Limited is ₹20.00 Cr, and the paid-up capital is ₹0.50 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX